Journal article
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
Abstract
BACKGROUND: Atherosclerotic peripheral arterial disease is associated with an increased risk of myocardial infarction, stroke, and death from cardiovascular causes. Antiplatelet drugs reduce this risk, but the role of oral anticoagulant agents in the prevention of cardiovascular complications in patients with peripheral arterial disease is unclear.
METHODS: We assigned patients with peripheral arterial disease to combination therapy with an …
Authors
Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C
Journal
The New England Journal of Medicine, Vol. 357, No. 3, pp. 217–227
Publisher
Massachusetts Medical Society
Publication Date
July 19, 2007
DOI
10.1056/nejmoa065959
ISSN
0028-4793